Cargando…

(11)C-Methionine PET for Identification of Pediatric High-Grade Glioma Recurrence

Differentiating tumor recurrence or progression from pseudoprogression during surveillance of pediatric high-grade gliomas (PHGGs) using MRI, the primary imaging modality for evaluation of brain tumors, can be challenging. The aim of this study was to evaluate whether (11)C-methionine PET, a molecul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bag, Asim K., Wing, Melissa N., Sabin, Noah D., Hwang, Scott N., Armstrong, Gregory T., Han, Yuanyuan, Li, Yimei, Snyder, Scott E., Robinson, Giles W., Qaddoumi, Ibrahim, Broniscer, Alberto, Lucas, John T., Shulkin, Barry L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society of Nuclear Medicine 2022
Materias:	Clinical Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051591/ https://www.ncbi.nlm.nih.gov/pubmed/34446453 http://dx.doi.org/10.2967/jnumed.120.261891

Ejemplares similares

LGG-22. SJ901: Phase I/II evaluation of single agent mirdametinib (PD-0325901), a brain-penetrant MEK1/2 inhibitor, for the treatment of children, adolescents, and young adults with low-grade glioma (LGG)
por: Vinitsky, Anna, et al.
Publicado: (2022)

Preoperative [(11)C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas
por: Ninatti, Gaia, et al.
Publicado: (2022)

NI-10 T2/FLAIR mismatch sign and methionine PET uptake in grade II and III gliomas
por: Ebiko, Yusuke, et al.
Publicado: (2020)

Phase II Trial of Erlotinib during and after Radiotherapy in Children with Newly Diagnosed High-Grade Gliomas
por: Qaddoumi, Ibrahim, et al.
Publicado: (2014)

NI-07 VALIDATION OF MACHINE LEARNING BASED HIGH GRADE GLIOMA MR SEGMENTATION VIA METHIONINE PET
por: Kinoshita, Manabu, et al.
Publicado: (2019)

Perfusion and diffusion MRI combined with (11)C-methionine PET in the preoperative evaluation of suspected adult low-grade gliomas
por: Berntsson, Shala Ghaderi, et al.
Publicado: (2013)

The performance of 11C-Methionine PET in the differential diagnosis of glioma recurrence
por: Xu, Weilin, et al.
Publicado: (2017)

Fractal analysis of (11)C-methionine PET in patients with newly diagnosed glioma
por: Maeda, Yukito, et al.
Publicado: (2021)

NI-8 Molecular diagnostic prediction combining T2-FLAIR mismatch sign, calcification, and methionine PET in grade II and III gliomas
por: Ebiko, Yusuke, et al.
Publicado: (2021)

Pediatric diencephalic tumors: a constellation of entities and management modalities
por: Pinto, Soniya N., et al.
Publicado: (2023)

Voxelwise Principal Component Analysis of Dynamic [S-Methyl-(11)C]Methionine PET Data in Glioma Patients
por: Martens, Corentin, et al.
Publicado: (2021)

NI-06 MOLECULAR DIAGNOSIS, 11C-METHIONINE UPTAKE AND PROGNOSIS IN GRADE 2 AND 3 GLIOMAS
por: Tamura, Kaoru, et al.
Publicado: (2019)

Tackling Pediatric Low-Grade Gliomas: A Global Perspective
por: Moreira, Daniel C., et al.
Publicado: (2023)

LGG-13. The clinical and molecular characteristics of progressive hypothalamic/optic pathway pilocytic astrocytoma
por: Li, Xiaoyu, et al.
Publicado: (2022)

Usefulness of [(11)C] Methionine PET in the Differentiation of Tumefactive Multiple Sclerosis from High Grade Astrocytoma
por: HASHIMOTO, Satoka, et al.
Publicado: (2019)

Diagnostic and Prognostic Significance of Methionine Uptake and Methionine Positron Emission Tomography Imaging in Gliomas
por: Palanichamy, Kamalakannan, et al.
Publicado: (2017)

Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma
por: He, Chen, et al.
Publicado: (2021)

Additive Value of Dynamic FDOPA PET/CT for Glioma Grading
por: Girard, Antoine, et al.
Publicado: (2021)

PET With (11)C-Methyl-l-Methionine as a Predictor of Consequential Outcomes at the Time of Discontinuing Temozolomide-Adjuvant Chemotherapy in Patients With Residual IDH-Mutant Lower-Grade Glioma
por: Beppu, Takaaki, et al.
Publicado: (2022)

Radiohistogenomics of pediatric low-grade neuroepithelial tumors
por: Bag, Asim K., et al.
Publicado: (2021)

PET Imaging with S-[(11)C]Methyl-L-Cysteine and L-[Methyl-(11)C]Methionine in Rat Models of Glioma, Glioma Radiotherapy, and Neuroinflammation
por: Parente, Andrea, et al.
Publicado: (2017)

Diagnostic accuracy of (13)N-ammonia PET, (11)C-methionine PET and (18)F-fluorodeoxyglucose PET: a comparative study in patients with suspected cerebral glioma
por: He, Qiao, et al.
Publicado: (2019)

The clinical and molecular characteristics of progressive hypothalamic/optic pathway pilocytic astrocytoma
por: Li, Xiaoyu, et al.
Publicado: (2022)

Dynamic (11)C-Methionine PET-CT: Prognostic Factors for Disease Progression and Survival in Patients with Suspected Glioma Recurrence
por: Mattoli, Maria Vittoria, et al.
Publicado: (2021)

Maximum 11C-methionine PET uptake as a prognostic imaging biomarker for newly diagnosed and untreated astrocytic glioma
por: Nakajo, Kosuke, et al.
Publicado: (2022)

PSMA Expression in 122 Treatment Naive Glioma Patients Related to Tumor Metabolism in (11)C-Methionine PET and Survival
por: Traub-Weidinger, Tatjana, et al.
Publicado: (2021)

Correlation of Intraoperative 5-ALA-Induced Fluorescence Intensity and Preoperative (11)C-Methionine PET Uptake in Glioma Surgery
por: Shimizu, Kazuhide, et al.
Publicado: (2022)

Outcomes of Children With Low-Grade Gliomas in Low- and Middle-Income Countries: A Systematic Review
por: Ward, Richard, et al.
Publicado: (2022)

[(18)F]-fluoro-l-thymidine PET and advanced MRI for preoperative grading of gliomas
por: Collet, S., et al.
Publicado: (2015)

STMO-11 Supratotal resection of Glioblastoma with Methionine PET
por: Ko, Ozaki, et al.
Publicado: (2020)

Diagnosing growth in low-grade gliomas with and without longitudinal volume measurements: A retrospective observational study
por: Fathallah-Shaykh, Hassan M., et al.
Publicado: (2019)

The Clinical Value of PET with Amino Acid Tracers for Gliomas WHO Grade II
por: Smits, Anja, et al.
Publicado: (2011)

[(18)F]Fluciclovine PET discrimination between high- and low-grade gliomas
por: Parent, Ephraim E., et al.
Publicado: (2018)

Radiotherapy in high grade gliomas
por: Bleehen, N.M., et al.
Publicado: (1989)

Pediatric low-grade glioma in the era of molecular diagnostics
por: Ryall, Scott, et al.
Publicado: (2020)

CD19 CAR T-cell therapy demonstrates activity against extramedullary disease in pediatric patients with B-ALL
por: Epperly, Rebecca, et al.
Publicado: (2023)

A Comparison of PET Tracers in Recurrent High-Grade Gliomas: A Systematic Review
por: Muthukumar, Sankar, et al.
Publicado: (2022)

HGG-03. HIGH-GRADE GLIOMA IN YOUNG CHILDREN IS HISTOLOGICALLY, MOLECULARLY, AND CLINICALLY DIVERSE—RESULTS FROM THE SJYC07 TRIAL AND INSTITUTIONAL EXPERIENCE
por: Chiang, Jason, et al.
Publicado: (2023)

Sex-specific radiomic features of L-[S-methyl-(11)C] methionine PET in patients with newly-diagnosed gliomas in relation to IDH1 predictability
por: Papp, Laszlo, et al.
Publicado: (2023)

Validation of magnetic resonance imaging-based automatic high-grade glioma segmentation accuracy via (11)C-methionine positron emission tomography
por: Ozaki, Tomohiko, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b024b81phk81nc7frd93kn8254